VINC Logo

Vincerx Pharma, Inc. (VINC) 

NASDAQ
Market Cap
$17.43M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
309 of 809
Rank in Industry
183 of 445

Largest Insider Buys in Sector

VINC Stock Price History Chart

VINC Stock Performance

About Vincerx Pharma, Inc.

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candidates include VIP217, an oral PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate to treat solid tumors; and VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is headquartered in Palo Alto, California.

Insider Activity of Vincerx Pharma, Inc.

Over the last 12 months, insiders at Vincerx Pharma, Inc. have bought $50,813 and sold $0 worth of Vincerx Pharma, Inc. stock.

On average, over the past 5 years, insiders at Vincerx Pharma, Inc. have bought $355,970 and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Hamdy Ahmed MD (See Remarks) — $21,161. Izumi Raquel E. (See Remarks) — $14,934. Seelenberger Alexander A. (See Remarks) — $9,968.

The last purchase of 10,500 shares for transaction amount of $9,968 was made by Seelenberger Alexander A. (See Remarks) on 2023‑08‑11.

List of Insider Buy and Sell Transactions, Vincerx Pharma, Inc.

2023-08-11PurchaseSeelenberger Alexander A.See Remarks
10,500
0.0503%
$0.95$9,968-2.94%
2023-08-10PurchaseTHOMAS TOM CSee Remarks
5,000
0.0241%
$0.95$4,750-4.91%
2023-08-10PurchaseHamdy Ahmed MDSee Remarks
5,400
0.0263%
$0.96$5,167-4.91%
2023-08-10PurchaseIzumi Raquel E.See Remarks
3,440
0.0163%
$0.93$3,199-4.91%
2023-08-09PurchaseHamdy Ahmed MDSee Remarks
16,900
0.0827%
$0.95$15,994-2.82%
2023-08-09PurchaseIzumi Raquel E.See Remarks
13,036
0.0607%
$0.90$11,735-2.82%
2022-12-14PurchaseHamdy Ahmed MDChief Executive Officer
35,280
0.1661%
$0.87$30,538+15.52%
2022-12-14PurchaseIzumi Raquel E.See Remarks
28,738
0.1383%
$0.88$25,427+15.52%
2022-12-14PurchaseTHOMAS TOM CSee Remarks
7,000
0.0316%
$0.83$5,810+15.52%
2022-08-24PurchaseLOWE CHRISTOPHER P.
18,400
0.0871%
$1.65$30,299-33.33%
2022-06-27PurchaseIzumi Raquel E.See Remarks
40,000
0.193%
$1.41$56,312-12.95%
2022-06-23PurchaseHamdy Ahmed MDChief Executive Officer
24,200
0.1121%
$1.41$34,137-16.55%
2022-06-09PurchaseBushnell Laura I.
15,000
0.0725%
$1.91$28,625-35.64%
2021-12-23PurchaseHwang SooinChief Business Officer
3,000
0.0144%
$10.00$30,000-84.35%
2021-12-22PurchaseHamdy Ahmed MDChief Executive Officer
6,450
0.0301%
$10.02$64,650-84.71%
2021-12-22PurchaseSeelenberger Alexander A.Chief Financial Officer
2,417
0.0116%
$10.34$24,988-84.71%
2021-12-22PurchaseBushnell Laura I.director
2,402
0.0117%
$10.48$25,173-84.71%
2021-12-22PurchaseTHOMAS TOM CSee Remarks
1,000
0.0048%
$10.23$10,230-84.71%
2021-08-04PurchaseIzumi Raquel E.See Remarks
1,000
0.0058%
$11.96$11,960-41.48%
2021-06-30PurchaseHwang SooinChief Business Officer
500
0.0028%
$12.66$6,330-24.44%

Insider Historical Profitability

<0.0001%
THOMAS TOM CSee Remarks
219935
1.0287%
$0.5940<0.0001%
Hamdy Ahmed MDSee Remarks
96060
0.4493%
$0.5960<0.0001%
Izumi Raquel E.See Remarks
85214
0.3986%
$0.5950<0.0001%
Seelenberger Alexander A.See Remarks
30280
0.1416%
$0.5930<0.0001%
Hwang SooinChief Business Officer
390491
1.8264%
$0.5920<0.0001%
LOWE CHRISTOPHER P.
28400
0.1328%
$0.5930<0.0001%
McDonald Andrew Idirector
20000
0.0935%
$0.5910<0.0001%
Bushnell Laura I.
19202
0.0898%
$0.5930<0.0001%
Lee John H.director
799
0.0037%
$0.5910<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Sage Rhino Capital LLC$8.62M5.771.7M0%+$02.15
Octagon Capital Advisors LP$5.06M3.391MNew+$5.06M0.66
Point72 Asset Management$4.83M3.23954,827+176.9%+$3.09M0.01
ROCK SPRINGS CAPITAL MANAGEMENT, LP$4.51M3.02891,7190%+$00.12
Bank of America$3.55M2.38701,423-35.23%-$1.93M<0.0001
The Vanguard Group$3.37M2.26666,995+29.91%+$777,089.34<0.0001
Goldman Sachs$3.2M2.14631,490-63.06%-$5.46M<0.01
Kingdon Capital Management$1.95M1.3385,0000%+$00.26
ExodusPoint Capital Management, LP$1.6M1.07316,642-2.31%-$37,828.700.02
Geode Capital Management$923,668.000.62182,483+18.47%+$144,014.52<0.0001
Citadel Advisors LLC$901,894.000.6178,240-9.69%-$96,742.10<0.01
Renaissance Technologies$614,000.000.41121,400-31.03%-$276,249.42<0.01
Helm Capital Management LLC$591,377.000.4116,873-67.02%-$1.2M0.02
Sio Capital Management LLC$516,368.000.35102,0490%+$00.18
Eversept Partners LP$402,715.000.2779,588New+$402,715.000.03
Marshall Wace$362,124.000.2471,566New+$362,124.00<0.0001
State Street$288,501.000.1957,016+32.16%+$70,197.39<0.0001
BlackRock$238,224.000.1647,080-26.73%-$86,925.45<0.0001
Northern Trust$173,685.000.1234,325+34.01%+$44,077.79<0.0001
T. Rowe Price$152,000.000.130,000-25%-$50,666.67<0.0001
Jane Street Capital$148,349.000.129,318New+$148,349.00<0.0001
Millennium Management LLC$131,277.000.0925,944-24.73%-$43,131.56<0.0001
Woodline Partners LP$119,644.000.0823,645New+$119,644.00<0.01
Morgan Stanley$99,313.000.0719,627+10.54%+$9,472.36<0.0001
Vontobel Holding Ltd$75,900.000.0515,000New+$75,900.00<0.01
LINSCO PRIVATE LEDGER CORP$69,676.000.0513,770New+$69,676.00<0.0001
American Century Investments$59,652.000.0411,789New+$59,652.00<0.0001
LMR PARTNERS LLP$50,600.000.0310,0000%+$0<0.01
Cresset Asset Management Llc$50,600.000.0310,000New+$50,600.00<0.0001
Acadian Asset Management$26,000.000.025,259-87.43%-$180,803.58<0.0001
Tower Research Capital$22,977.000.024,541-15.11%-$4,088.40<0.0001
Qube Research & Technologies$12,534.000.012,477+61,825%+$12,513.76<0.0001
UBS$12,640.000.012,498-15.29%-$2,282.08<0.0001
Ica Group Wealth Management Llc$1,518.00<0.01300New+$1,518.00<0.0001
Wells Fargo$810.00<0.01160+20.3%+$136.69<0.0001
Macquarie Group$1,000.00<0.01266New+$1,000.00<0.0001
Barclays$0<0.01230%+$0<0.0001